UR-144

CAS No. 1199943-44-6

UR-144( UR 144 | UR144 )

Catalog No. M10716 CAS No. 1199943-44-6

A potent, selective full agonist of the peripheral cannabinoid receptor CB2 with Ki of 1.8 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    UR-144
  • Note
    Research use only, not for human use.
  • Brief Description
    A potent, selective full agonist of the peripheral cannabinoid receptor CB2 with Ki of 1.8 nM.
  • Description
    A potent, selective full agonist of the peripheral cannabinoid receptor CB2 with Ki of 1.8 nM, >80-fold selectivity over CB2 (Ki=150 nM); possesses an EC50 of 421 nM for human CB1 receptors, and 72 nM for human CB2 receptors, produces bradycardia and hypothermia in rats at a dose of 10 mg/kg.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    UR 144 | UR144
  • Pathway
    GPCR/G Protein
  • Target
    Cannabinoid Receptor
  • Recptor
    Cannabinoid Receptor
  • Research Area
    Neurological Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    1199943-44-6
  • Formula Weight
    311.461
  • Molecular Formula
    C21H29NO
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CCCCCn1cc(c2c1cccc2)C(=O)C3C(C3(C)C)(C)C
  • Chemical Name
    (1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Banister SD, et al. ACS Chem Neurosci. 2015 Aug 19;6(8):1445-58. 2. Dhopeshwarkar A, et al. J Pharmacol Exp Ther. 2016 Aug;358(2):342-51.
molnova catalog
related products
  • Otenabant

    A potent, and selective CB1 receptor antagonist with Ki of 0.7 nM/0.12 nM in binding and functional assays respectively; has low affinity (Ki=7600 nM) for human CB2 receptors; reverses cannabinoid agonist mediated responses, reduces food intake, and increases energy expenditure and fat oxidation in rodents.ObesityPhase 3 Discontinued

  • JTE907

    A potent, selective, orally active cannabinoid CB2 receptor inverse agonist with Ki of 35.9, 1.55 and 0.38 nM for human, mouse and rat CB2, respectively.

  • NESS-0327

    A potent, selective CB1 cannabinoid receptor antagonist with Ki of 350 fM.